65
Participants
Start Date
August 31, 2006
Primary Completion Date
January 31, 2009
Tipranavir
Ritonavir
low dose
Boehringer Ingelheim Investigational Site, Aachen
Boehringer Ingelheim Investigational Site, Berlin
Boehringer Ingelheim Investigational Site, Bremen
Boehringer Ingelheim Investigational Site, Cologne
Boehringer Ingelheim Investigational Site, Dortmund
Boehringer Ingelheim Investigational Site, Düsseldorf
Boehringer Ingelheim Investigational Site, Erlangen
Boehringer Ingelheim Investigational Site, Frankfurt am Main
Boehringer Ingelheim Investigational Site, Freiburg im Breisgau
Boehringer Ingelheim Investigational Site, Giessen
Boehringer Ingelheim Investigational Site, Halle
Boehringer Ingelheim Investigational Site, Hamburg
Boehringer Ingelheim Investigational Site, Hanover
Boehringer Ingelheim Investigational Site, Homburg/Saar
Boehringer Ingelheim Investigational Site, Karlsruhe
Boehringer Ingelheim Investigational Site, Krefeld
Boehringer Ingelheim Investigational Site, Leipzig
Boehringer Ingelheim Investigational Site, Magdeburg
Boehringer Ingelheim Investigational Site, Mainz
Boehringer Ingelheim Investigational Site, München
Boehringer Ingelheim Investigational Site, Münster
Boehringer Ingelheim Investigational Site, Nuremberg
Boehringer Ingelheim Investigational Site, Oldenburg
Boehringer Ingelheim Investigational Site, Osnabrück
Boehringer Ingelheim Investigational Site, Saarbrücken
Boehringer Ingelheim Investigational Site, Stuttgart
Boehringer Ingelheim Investigational Site, Wuppertal
Lead Sponsor
Boehringer Ingelheim
INDUSTRY